[ad_1]
Oxford did not immediately respond to a request for comment from Reuters. (Representative)
Oxford scientists are preparing to rapidly produce new versions of their vaccine to fight the more contagious emerging variants of COVID-19 found in the UK, South Africa and Brazil, the Telegraph reported on Wednesday.
The team behind the vaccine from Oxford and AstraZeneca Plc is undertaking feasibility studies to reconfigure the technology, the journal said, citing confirmation from the University of Oxford.
Scientists were working to estimate how quickly they could reconfigure their ChAdOx vaccine platform, according to the report.
A spokesperson for the university told the newspaper that Oxford is carefully evaluating the impact of the new variants on vaccine immunity and evaluating the processes necessary for the rapid development of tuned COVID-19 vaccines.
Oxford did not immediately respond to a request for comment from Reuters.
Separately, British Prime Minister Boris Johnson said on Wednesday that the national drug regulator would be ready and able to approve new versions of COVID-19 vaccines designed to counter new variants of the coronavirus that may appear.
(Except for the title, this story was not edited by NDTV staff and is posted from a syndicated feed.)
[ad_2]
Source link